Boosting the hypoxia-induced adaptive response in inflammatory bowel disease: A novel concept of treatment

Inflammatory Bowel Diseases

Volumn 17, Issue 9, 2011, Pages 2019-2022

  Hindryckx, Pieter ^a   Laukens, Debby ^a   De Vos, Martine ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

HIF 1, hydroxylases; hypoxia; IBD

Indexed keywords

DEFEROXAMINE; DIMETHYLOXALYLGLYCINE; GASTROINTESTINAL AGENT; HYDROXYLASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; HYPOXIA INDUCIBLE FACTOR 3; INTESTINAL TREFOIL FACTOR; MUCIN; OXYGENASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PYRIDINE DERIVATIVE; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE COLITIS; ADAPTIVE IMMUNITY; CHRONIC INFLAMMATION; DRUG TARGETING; ENTERITIS; ENZYME INHIBITION; HUMAN; HYPOXIA; INTESTINAL EPITHELIAL BARRIER DYSFUNCTION; INTESTINE EPITHELIUM; NONHUMAN; OXYGEN SENSING; PRIORITY JOURNAL; PROTECTION; REVIEW;

ANOXIA; ENZYME INHIBITORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; INFLAMMATORY BOWEL DISEASES; MIXED FUNCTION OXYGENASES; OXYGEN;

EID: 80051509780     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21589     Document Type: Review

References (32)

1. Karhausen J, Volker VH, Colgan SP,. Inflammatory hypoxia: role of hypoxia-inducible factor. Cell Cycle. 2005; 4: 256-268.
2. Hatoum OA, Binion DG, Gutterman DD,. Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease. Eur J Clin Invest. 2005; 35: 599-609. (Pubitemid 41406724)
3. Karhausen J, Furuta GT, Tomaszewski JE, et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest. 2004; 114: 1098-1106. (Pubitemid 39578699)
4. Taylor CT, Colgan SP,. Hypoxia and gastrointestinal disease. J Mol Med. 2007; 85: 1295-1300. (Pubitemid 50004090)
5. Taylor C, Dzus A, Colgan S,. Autocrine regulation of epithelial permeability by hypoxia: Role for polarized release of tumor necrosis factor α. Gastroenterology. 1998; 114: 657-668. (Pubitemid 28160400)
6. Hindryckx P, Waeytens A, Laukens D, et al. Absence of placental growth factor blocks dextran sodium sulfate-induced colonic mucosal angiogenesis, increases mucosal hypoxia and aggravates acute colonic injury. Lab Invest. 2010; 90: 566-576.
7. Irvine EJ, Marshall JK,. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology. 2000; 119: 1740-1744. (Pubitemid 32198699)
8. Gibson PR,. Increased gut permeability in Crohn's disease: is TNF the link? Gut. 2004; 53: 1724-1725. (Pubitemid 39556884)
9. Semenza GL,. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3: 721-732. (Pubitemid 37328811)
10. Kaelin WG, Ratcliffe PJ,. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008; 30: 393-402. (Pubitemid 351681994)
11. Fraisl P, Aragones J, Carmeliet P,. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov. 2009; 8: 139-152.
12. Hirota SA, Beck PL, MacDonald JA,. Targeting hypoxia inducible factor-1 (HIF-1) signaling in therapeutics: implications for the treatment of inflammatory bowel disease. Recent Pat Inflamm Allergy Drug Discov. 2009; 3: 1-16.
13. Tambuwala MM, Cummins EP, Lenihan CR, et al. Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology. 2010 [Epub ahead of print].
14. Giatromanolaki A, Sivridis E, Maltezos E, et al. Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease. J Clin Pathol. 2003; 56: 209-213. (Pubitemid 36308037)
15. Synnestvedt K, Furuta GT, Comerford KM, et al. Ecto-5 2-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest. 2002; 110: 993-1002.
16. Furuta GT, Turner JR, Taylor CT, et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med. 2001; 193: 1027-1034. (Pubitemid 32436196)
17. Louis NA, Hamilton KE, Canny G, et al. Selective induction of mucin-3 by hypoxia in intestinal epithelia. J Cell Biochem. 2006; 99: 1616-1627. (Pubitemid 44845721)
18. Cummins EP, Seeballuck F, Keely SJ, et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology. 2008; 134: 156-165.
19. Hindryckx P, De Vos M, Jacques P, et al. Hydroxylase inhibition abrogates TNF-α-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD. J Immunol. 2010; 185: 6306-6316.
20. Robinson A, Keely S, Karhausen J, et al. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology. 2008; 134: 145-155. (Pubitemid 350309309)
21. Morote-Garcia JC, Rosenberger P, Nivillac NM, et al. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology. 2009; 136: 607-618.
22. Rosenberger P, Schwab JM, Mirakaj V, et al. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol. 2008; 10: 195-202.
23. Zheng W, Kuhlicke J, Jäckel K, et al. Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium. FASEB J. 2009; 23: 204-213.
24. Keely S, Glover LE, MacManus CF, et al. Selective induction of integrin beta1 by hypoxia-inducible factor: implications for wound healing. FASEB J. 2009; 23: 1338-1346.
25. Shah YM, Ito S, Morimura K, et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology. 2008; 134: 2036-2048.
26. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell. 2008; 134: 743-756.
27. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007; 39: 207-211. (Pubitemid 46184351)
28. Wilkinson S, O'Prey J, Fricker M, et al. Hypoxia-selective macroautophagy and cell survival signaled by autocrine PDGFR activity. Genes Dev. 2009; 23: 1283-1288.
29. Ye J, Koumenis C,. ATF4, an ER stress and hypoxia-inducible transcription factor and its potential role in hypoxia tolerance and tumorigenesis. Curr Mol Med. 2009; 9: 411-416.
30. Mazzone M, Dettori D, Leite de Oliveira R, et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell. 2009; 136: 1-13.
31. Taylor CT,. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol. 2008; 586: 4055-4059.
32. Chen LW, Egan L, Li ZW, et al. The two faces of IKKc and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med. 2003; 9: 575-581. (Pubitemid 36597104)